The following information is excerpted from Arthritis Today Special Report dated 10/98: "The New Drugs; what to expect"

 

 

 

 

By Mary Anne Dunkin

 

 

 

 

 

 

 

 

 

 

"New and Improved..."

As consumers we hear words so much we know to be cynical. "New" often means repackaged, redesigned or repriced. In a realm of arthritis treatment, "new" options in recent years have usually been new formulations of exiting drugs or new uses for existing drugs. Improvements, certainly, but not really new.

But now, as we approach the millennium, all that is changing. With the accumulation of knowledge from research and advances in molecular technology, drug companies are developing and testing new treatments at an unprecedented rate. That's right, treatments that are "new"-never before used for arthritis or any other disease. You're probably already hearing about them. In the popular press, they've been touted as "breakthroughs," "exciting treatments options" and "super aspirins." A number of these new drugs have either come out recently or will be available shortly. Three of these will be used to treat rheumatoid arthritis (RA), two to treat osteoarthritis (OA), and two will be used to help treat any form of arthritis that involves pain and inflammation.

The RA drugs are leflunomide (Arava), a disease-modifying antirheumatic drug and infliximab (Remicade) and entanercept (Enbrel), two drugs from a relatively new class called biologic response modifiers (BRMs), or biologic agents. The two new OA drugs are hyaluronan (Hyalgan) and hylan GF20 (Synvisc) and are in a new category called viscosupplements of=r hyaluronic acid substitutes. (Interestingly, these are classified by FDA not as drugs, but as medical devices.) The remaining two drugs are celecoxib (Celebrex) and Vioxx (at press time, there was no generic name for this drug), both from a new class called COX-2 inhibitors.

Arthritis Foundation

Chances are you or someone close to you has arthritis. Arthritis, which means inflammation of the joints, causes pain and loss of movement. It is an umbrella term for more than 120 diseases and conditions (such as lupus, carpal tunnel syndrome, osteoporosis, gout and fibromyalgia). Arthritis affects an estimated 43 million Americans - that's one in six people, including nearly 300,000 children. It strikes women twice as often as men and is America's #1 chronic, debilitating disease, costing the U.S. economy over $65 billion annually.

The mission of the Arthritis Foundation is to support research to find the cure for and prevention of arthritis and to improve the quality of life for those affected by arthritis. For more information about arthritis or opportunities to help, please call the Arthritis Foundation at 1 (800) 954-CURE.

PETS HAVE ARTHRITIS TOO!

Arthritis is a disease, which is commonly found in small animals, especially dogs. The severity of arthritis is often shown by lameness, pain and loss of jumping ability in dogs. Veterinarians have access to all of the modern ways to diagnose and treat this disease. Annual check-ups at your veterinarian is the best way to insure your pet's health. - Dr. Ron Rowley, D.V.M. Crenshaw Animal Hospital

Back to top

 

 

Hosted by www.Geocities.ws

1